Hepatic-specific DUSP22 deletion particularly exacerbates lipid deposition, inflammatory response and fibrosis in liver, facilitating NASH and non-alcoholic fatty liver disease (NAFLD)-associated HCC progression. The gene discussed is DUSP22; the disease is metabolic dysfunction-associated steatohepatitis.